Search Medical Condition
Please enter condition
Please choose location from dropdown

Hearing Impairment Clinical Trials

A listing of Hearing Impairment medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (60) clinical trials

Outcome Prediction in Cochlear Implant Recipients

The ability to predict post-operative outcomes after implantation is important for a number of reasons, including being able to advise candidates of appropriate expectations using evidence based guidance. The approved study involves investigation of the ability to predict outcomes in the implanted ear alone and in the best-aided binaural listening ...

Phase N/A

Cochlear Implant Low Power Strategy

Reducing power consumption in the cochlear implant is crucial to the development of future smaller sound processors. The commercial MP3000 sound coding strategy has been shown to be more efficient in power consumption to the standard ACE strategy. However in order to develop smaller sound processors, further battery life power ...

Phase N/A

Efficacy Safety and Tolerability of Ancrod in Patients With Sudden Hearing Loss

The purpose of this study is to determine whether ancrod is effective and safe in the treatment of sudden sensorineural hearing loss (SSHL).

Phase

Wolfram Syndrome International Registry and Clinical Study

Background Wolfram syndrome (OMIM #222300) is an autosomal recessive disorder characterized by insulin dependent diabetes mellitus (DM) in the first decade of life, followed by optic atrophy (OA), blindness, and deafness. Death from widespread neurodegeneration occurs in the third or fourth decades. Postmortem studies revealed a non-autoimmune loss of pancreatic ...

Phase N/A

Benefits of the HiResolution Bionic Ear System in Adults With Asymmetric Hearing Loss

The purpose of this feasibility study is to evaluate the benefit of unilateral implantation in adults who have severe to profound sensorineural hearing loss in one ear, and up to moderate sensorineural hearing loss in the other ear (asymmetric hearing loss).

Phase N/A

Auditive and Renal Long Term Outcomes - Risk After Aminoglycoside Therapy in Neonates (AURORA)

Gentamicin, in combination with a beta-lactam antibiotic, is commonly used for treatment of neonatal sepsis. Neonates have a high volume of distribution. It is a paradox that most neonatal dosing schedules still recommend lower gentamicin doses (4-5 mg/kg) than in older children ( 7 mg/kg). In the neonatal unit in ...

Phase N/A

Auditory Rehabilitation and Cognition in Alzheimer Patients

Alzheimer disease is a neurodegenerative disease. Recent studies suggest that subjects with hearing loss are more likely to develop Alzheimer's disease. Hearing loss can be consecutive to presbycusis and/or to central auditory dysfunction. Standard audiometric measures with pure tone and speech intelligibility allow the diagnosis of presbycusis. However, to demonstrate ...

Phase N/A

The Neuro Zti Cochlear Implant System Efficacy and Safety in Adults

The new cochlear implant system is indicated in individuals with serious hearing disabilities who do not obtain benefit from appropriately fitted hearing aid(s). Cochlear implant surgery is safe, but as with any surgery, possible issues or device related issues may occur. The risk benefit balance is well known in cochlear ...

Phase N/A

Cochlear Implant With Anti-Inflammatory Agent

In an effort to further preserve residual acoustic hearing after cochlear implantation, it may be beneficial to incorporate anti-inflammatory agents into the electrode array for passive elution over a time course after implantation. This study aims to assess the ease and effectiveness of such an electrode design, and to assess ...

Phase N/A

Administration of Dexamethasone in PONV Prophylaxis in Children Undergoing Adenotomy

Randomization The study subjects were randomized into two arms, using computer-generated sequence of binary code: interventional arm with dexamethasone administration and control group with a placebo - physiological solution. Anaesthesiology nurse, who was not a part of the research team, randomly selected a vial for each enrolled patient, which was ...

Phase N/A